YUMANITY THERAPEUTICS, INC. (YMTX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 32 transactions totaling $85.4K, demonstrating a bearish sentiment with -$85.4K in net insider flow. The most recent transaction on Dec 2, 2022 involved a sale of 3,116 shares valued at $5.3K.
No significant insider buying has been recorded for YMTX in the recent period.
No significant insider selling has been recorded for YMTX in the recent period.
Based on recent SEC filings, insider sentiment for YMTX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$85.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at YUMANITY THERAPEUTICS, INC. (YMTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading YMTX stock, having executed 32 transactions in the past 90 days. The most active insider is Richard Peters (Executive), who has made 8 transactions totaling $109.0K.
Get notified when executives and directors at YMTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Whittemore Smith Devin | Executive | Sale | 3,116 | $1.69 | $5.3K | |
| Dec 2, 2022 | Epstein Marie | Executive | Sale | 1,976 | $1.69 | $3.3K | |
| Dec 2, 2022 | D. Wyzga Michael | Executive | Sale | 3,116 | $1.69 | $5.3K | |
| Dec 2, 2022 | Peters Richard | Executive | Sale | 10,890 | $1.69 | $18.4K | |
| Jul 5, 2022 | Peters Richard | Executive | Sale | 4,584 | $1.85 | $8.5K | |
| Jun 3, 2022 | Peters Richard | Executive | Sale | 10,206 | $1.19 | $12.1K | |
| Jun 3, 2022 | D. Wyzga Michael | Executive | Sale | 2,887 | $1.19 | $3.4K | |
| Jun 3, 2022 | Whittemore Smith Devin | Executive | Sale | 2,923 | $1.19 | $3.5K | |
| Jun 3, 2022 | Epstein Marie | Executive | Sale | 1,806 | $1.19 | $2.1K | |
| Mar 28, 2022 | Peters Richard | Executive | Sale | 10,715 | $1.85 | $19.8K | |
| Feb 3, 2022 | Mohsen Paulash | Executive | Sale | 1,958 | $1.83 | $3.6K | |
| Dec 1, 2021 | Peters Richard | Executive | Award | 70,000 | $N/A | $0 | |
| Dec 1, 2021 | Whittemore Smith Devin | Executive | Award | 20,000 | $N/A | $0 | |
| Dec 1, 2021 | Mohsen Paulash | Executive | Award | 20,000 | $N/A | $0 | |
| Dec 1, 2021 | D. Wyzga Michael | Executive | Award | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 19 | $100.0K | 42.4% |
Sale(S) | 11 | $85.4K | 36.2% |
Payment(F) | 2 | $50.2K | 21.3% |
Insider selling pressure at YUMANITY THERAPEUTICS, INC. has increased, with 11 insiders executing 32 transactions across all time. Total sales of $85.4K significantly outpace purchases of $0, resulting in a net outflow of $85.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.